A Second Study of NicVAX/Placebo as an Aid for Smoking Cessation

Completed · Phase 3 · Has a placebo group

Conditions studied: Smoking Cessation

In brief

The purpose of this study is to evaluate NicVAX as an aid to smoking cessation for long term abstinence.

Key facts

Study ID

NCT01102114

Run by

Nabi Biopharmaceuticals

People needed

1000

Starts

2010-03-01

Expected to finish

2011-11-01

Last updated by the study team

2012-05-09

Who can join

Age: 18 and older, up to 65. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Current smoker who smokes at least 10 cigarettes a day during the past year and wants to quit smoking.
• Smokers who are in good general health.

You may not qualify if…

• Prior exposure to NicVAX or any other nicotine vaccine.
• Use of systemic steroids.
• Cancer or cancer treatment in the last 5 years.
• HIV infection.
• History of drug or alcohol abuse or dependence within 12 months.
• Significant cardiovascular, hepatic, renal, psychiatric and/or respiratory disease.
• Inability to fulfill all visits for approximately 52 weeks.

Where it is running

• NicVAX Investigator — Encino, California, United States
• NicVAX Investigator — Los Alamitos, California, United States
• NicVAX Investigator — Denver, Colorado, United States
• NicVAX Investigator — New Haven, Connecticut, United States
• NicVAX Investigator — Brooksville, Florida, United States
• NicVAX Investigator — Orlando, Florida, United States
• NicVAX Investigator — Pembroke Pines, Florida, United States
• NicVAX Investigator — Tampa, Florida, United States
• NicVAX Investigator — Indianapolis, Indiana, United States
• NicVAX Investigator — Wichita, Kansas, United States
• NicVAX Investigator — Metairie, Louisiana, United States
• NicVAX Investigator — Annapolis, Maryland, United States
• NicVAX Investigator — Milford, Massachusetts, United States
• NicVAX Investigator — East Lansing, Michigan, United States
• NicVAX Investigator — Rochester, Minnesota, United States
• NicVAX Investigator — Jackson, Mississippi, United States
• NicVAX Investigator — Omaha, Nebraska, United States
• NicVAX Investigator — Buffalo, New York, United States
• NicVAX Investigator — Cincinnati, Ohio, United States
• NicVAX Investigator — Mt. Pleasant, South Carolina, United States
• NicVAX Investigator — Knoxville, Tennessee, United States
• NicVAX Investigator — Nashville, Tennessee, United States
• NicVAX Investigator — Houston, Texas, United States
• NicVAX Investigator — Salt Lake City, Utah, United States
• NicVAX Investigator — Charleston, West Virginia, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.